In COVID, a Catalyst for Changing Healthcare Delivery
During lockdown, health systems globally have had to cope with the challenge of sustaining capacity to provide care for COVID patients, as well as providing continued care for those suffering from other ailments that require ongoing management.
Modern Medicine – Issue 5 2020
Hypertension, Drugs and COVID-19 Risk
Arterial hypertension is the leading cause of death in the world and is frequently accompanied by other comorbidities such as diabetes, obesity, chronic kidney disease and established cardiovascular disease of different types. Patients suffering from infection by SARS-CoV-2 frequently present with arterial hypertension and these accompanying comorbidities. Concern has been expressed that medical therapy for cardiovascular disease might specifically contribute to the severity of illness in patients with COVID-19.
Modern Medicine – Issue 4 2020
Managing Asthma and COVID-19 Risk
In the face of unchartered territory and unprecedented times, there remains uncharted much to be learned about the impact of asthma on the course of SARS-CoV-2 virus infection. Although adult data suggest that asthma is a risk factor for COVID-19 morbidity and mortality, such a risk in children is unclear. Differentiating COVID- 19 from worsening asthma, or an asthma exacerbation, is challenging. There is broad consensus that asthma exacerbations should be treated aggressively and in keeping with current guideline recommendations.
Modern Medicine – Issue 4 2020
Contact Tracing: A Critical Tool to Combat COVID-19
At a time when the world is grappling with COVID-19, the role of contact tracing has been invaluable in slowing the spread of the virus. Across the globe, thousands of health professionals have been recruited to fulfil this essential but relentless task – whether in wide-scale community testing or hotspot testing strategies.
Modern Medicine – Issue 4 2020
